TC BIOPHARM HOLDINGS PLC-ADR (TCBP)

US87807D4007 - ADR

0.66  +0 (+0.15%)

After market: 0.65 -0.01 (-1.52%)

TC BIOPHARM HOLDINGS PLC-ADR

NASDAQ:TCBP (12/20/2024, 8:00:00 PM)

After market: 0.65 -0.01 (-1.52%)

0.66

+0 (+0.15%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS SubIndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%-88.9%
Sales Q2Q%-100%
CRS0.19
6 Month-92.41%
Overview
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Ins Owners0%
Inst Owners1.77%
Market Cap5.42M
Shares8.21M
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts82.86
Short Float %3.6%
Short Ratio0.01
IPO02-23 2022-02-23
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

TCBP Daily chart

Company Profile

TC Biopharm (Holdings) PLC is a GB-based company operating in Biotechnology industry. The company employs 41 full-time employees The company went IPO on 2022-02-23. TC BioPharm (Holdings) plc is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of gamma-delta T cell therapies (GD-Ts) for the treatment of cancer with human efficacy data in acute myeloid leukemia. The firm is conducting two investigator-initiated clinical trials for its unmodified gamma-delta T cell product line - phase IIb/III pivotal trial in treatment of acute myeloid leukemia using its proprietary allogeneic CryoTC technology to provide frozen product to clinics worldwide. Its lead product is TCB-008. In addition to unmodified allogenic GD-Ts for treatment of blood cancers, the Company is also developing an expanded platform for TCB-008 use case in anti-fungal, anti-viral and anti-microbial diseases. Its unmodified cell therapy, used in the treatment of acute myeloid leukemia, is supplied under the name OmnImmune. The company is also developing a range of genetically modified CAR-T products for the treatment of solid cancers.

Company Info

TC BIOPHARM HOLDINGS PLC-ADR

Maxim 1, 2 Parklands Way, Holytown

Honiton

P: 441414337557

Employees: 41

Website: https://www.tcbiopharm.com

TCBP News

News Image2 days ago - TC BioPharmTCBP Advances ACHIEVE Phase 2b Clinical Trial with Final Dosing of 3 Patients

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform...

ChartMill News Image4 days ago - ChartmillKeep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.

Let's take a look at the stocks that are in motion in today's session.

ChartMill News Image4 days ago - ChartmillThese stocks are moving in today's pre-market session

As the US market prepares to open on Wednesday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

News Image4 days ago - TC BioPharmTCBP Announces General Meeting of Shareholders to Approve One-Time Shareholder Dividend

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform...

News Image4 days ago - Yahoo FinanceEXCLUSIVE: Penny Stock TC BioPharm Proposes Special Stock Dividend

On Wednesday, TC BioPharm (Holdings) PLC (NASDAQ:TCBP) announced that its Board of Directors approved a special dividend of 0.25 American Depositary Shares for every 1 ADS held by shareholders, pending shareholder approval. The company intends to hold a general meeting of shareholders on Monday, December 30. The dividend is expected to be declared on December 30, 2024, and payable to shareholders who own the company's stock at the close of trading on January 02, 2025. "We are extremely pleased t

News Image11 days ago - TC BioPharmTCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

/PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP) a clinical-stage biotechnology company developing platform...

TCBP Twits

Here you can normally see the latest stock twits on TCBP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example